[
  {
    "objectID": "02R-tist.html",
    "href": "02R-tist.html",
    "title": "Zero to R-tist",
    "section": "",
    "text": "Substantial free training is available for R. A few links to get you started are provided below\n\nR Studio Starting Links\n\nRStudio Education (Beginners)\nRStudio Education (Intermediates)\nRStudio Education (Experts)\nRStudio Webinars - RStudio\n\nR Studio Cheat sheets\neBooks\n\nAdvanced R - Hadley Wickham\nR Packages - Hadley Wickham\nR for Data Science - Garrett Grolemund, Hadley Wickham.\nbookdown: Authoring Books and Technical Documents with R Markdown - Yihui Xie\nEfficicient R Programming - Colin Gillespie, Robin Lovelace\nquarto\nTidyverse Style Guide\nrOpenSci Package development\nR Packages (2e)\n\nBlogs/ Videos\n\nR-bloggers\nRStudio\nR Views\nYouTube\n\nGuided Learning (NOTE: this is a range of free and paying courses)\n\nposit\nedx courses\ndatacamp\ncoursera\nMOOC"
  },
  {
    "objectID": "news.html",
    "href": "news.html",
    "title": "News",
    "section": "",
    "text": "Date\n\n\n\nTitle\n\n\n\nAuthor\n\n\n\n\n\n\n\n\nJul 17, 2025\n\n\nOne Day meeting on Change Management in the Transition to Open-Source / R\n\n\nMartin Brown\n\n\n\n\n\n\nNov 20, 2023\n\n\n2023: A Year of Progress for PHUSE CAMIS Working Group\n\n\nLyn Taylor\n\n\n\n\n\n\nSep 14, 2023\n\n\nR and FDA Submission\n\n\nMartin Brown\n\n\n\n\n\n\nAug 28, 2023\n\n\nFDA Pilot 3 submission\n\n\nLyn Taylor\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "minutes/2024-02-16/index.html",
    "href": "minutes/2024-02-16/index.html",
    "title": "Minutes 2024-02-16",
    "section": "",
    "text": "TipView Attendee List\n\n\n\n\n\n\nMartin Brown\nChristina Fillmore\nAlexandra Lauer\nMatthew Neilson\nIrene Vassallo"
  },
  {
    "objectID": "minutes/2024-02-16/index.html#admin",
    "href": "minutes/2024-02-16/index.html#admin",
    "title": "Minutes 2024-02-16",
    "section": "Admin",
    "text": "Admin\nLyn has left AIMS to fully concentrate on leading CAMIS."
  },
  {
    "objectID": "minutes/2024-02-16/index.html#psi-and-2024-events",
    "href": "minutes/2024-02-16/index.html#psi-and-2024-events",
    "title": "Minutes 2024-02-16",
    "section": "PSI and 2024 events",
    "text": "PSI and 2024 events\nEnd of year 2023 achievements, highlights and updates are to be sent to Adam Crisp by Friday 1st March. Awareness of requirement for SIGs to be active year to year to not be considered closed.\nESIG leaders‚Äô meeting planned for Monday 25th March - looking to ask about digital strategy update.\nFed back about PSI Webinar: Open Source Software - is it really a free-for-all? that the SIG hadn‚Äôt heard anything about https://psiweb.org/events/event-item/2024/04/17/default-calendar/psi-webinar-open-source-solutions‚Äîis-it-really-a-free-for-all Will look to speak to Adam about this (training group comms) and SIG plans / future conferences.\n\nGitHUB workshop\nChristina and Alex to run it - will look to select dates. Details to be worked out (2 x 1-1.5 sessions with session 1 all about initial set up with drop-in afterwards?)\n\n\nNovo Nordisk FDA submission\nVideo summary from Appsilon blog can be found at: https://appsilon.com/first-r-based-submission-to-fda-by-novo-nordisk/ Add to the website in the news section."
  },
  {
    "objectID": "minutes/2024-02-16/index.html#r-training-open-source",
    "href": "minutes/2024-02-16/index.html#r-training-open-source",
    "title": "Minutes 2024-02-16",
    "section": "R Training Open Source",
    "text": "R Training Open Source\nAndy focused on the current training session and then will look to release by April."
  },
  {
    "objectID": "minutes/2024-02-16/index.html#focus",
    "href": "minutes/2024-02-16/index.html#focus",
    "title": "Minutes 2024-02-16",
    "section": "2024 Focus",
    "text": "2024 Focus\nStatistics focus What are the gaps? Can we pull particular package names from CAMIS or just carry on linking to CAMIS website?\nWill look to bring together the materials from the simulation course and work out what is the best way to advertise them. Matt to send them through.\nMentioned the idea of supporting particular groups - pointing them in the right direction of R material and links. Christina made the points:\n\nWhat are the problems people are facing? What support do they require?\nThey are more likely to be comfortable and already set specifically in those different areas.\n\nSo let us look to reach out to the contacts and potentially they could contribute to our website in different ways.\n\nHTA\n\nData science\nBiomarkers\nVisualisation\nDSMB (Michael)\nRegulatory (Florian)\nBayesian borrowing"
  },
  {
    "objectID": "minutes/2024-02-16/index.html#website",
    "href": "minutes/2024-02-16/index.html#website",
    "title": "Minutes 2024-02-16",
    "section": "Website",
    "text": "Website\nTalked about problems with AIMS logo not showing on homepage - issue to do with space in filename. Talked about importance of what homepage is trying to achieve, good load times and CSS for hexes and collapsible boxes: https://www.w3schools.com/howto/howto_js_collapsible.asp"
  },
  {
    "objectID": "minutes/2024-01-19/index.html",
    "href": "minutes/2024-01-19/index.html",
    "title": "Minutes 2024-01-19",
    "section": "",
    "text": "TipView Attendee List\n\n\n\n\n\n\nMartin Brown\nLyn Taylor\nChris Toffis\nMichael Cartwright\nChristina Fillmore\nMatthew Neilson\nCamilo Rojas Cifuentes\nIrene Vassallo\nAlexandra Lauer"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#admin-2024-goals",
    "href": "minutes/2024-01-19/index.html#admin-2024-goals",
    "title": "Minutes 2024-01-19",
    "section": "Admin / 2024 Goals",
    "text": "Admin / 2024 Goals\nCouple of meetings back Martin mentioned interest from someone in the US to join AIMS. Upon further communication, found that she had moved from academia to industry and was just interested in finding orientation. So provided some information particularly relevant to US industry groups.\nMinutes now to be included on website and not sent out in a word document.\nMartin outlined some potential areas for goals in 2024:\n\nWebsite release/communication\nEvents\nR training open source release\nClinical flow chart diagram for R (from data to output)\nData science collaboration on using R with AI/ML"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#psi-conference-2024-events",
    "href": "minutes/2024-01-19/index.html#psi-conference-2024-events",
    "title": "Minutes 2024-01-19",
    "section": "PSI Conference / 2024 events",
    "text": "PSI Conference / 2024 events\nDiscussed PSI conference abstract rejection notes\nGeneral feeling from committee that R validation has been done?\nSet out problem/landscape more and then response to that in session\nWill look to meet with Adam Crisp and discuss conference issues\n\nPSI conference more set to individuals now?\nConference is a good opportunity to get together as a SIG\nPressure to reduce travel so focus on 1 conference where attendance based on presenting\n\nPossible to do decent workshops online if effort put in\nGitHUB workshop plans - September - 4 x 1 hour\nAlex not able to present (Kevin could potentially instead?), Irene to help with prep before maternity leave\nNovo Nordisk - dont have any elements written down\n\nCan we get their information as a blog?\nInformation all in separate webinars\nBetter to get understanding from quicker mediums like blogs.\n\nSpeak to Florian about raw data pilot and get more information on that?"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#r-training-open-source",
    "href": "minutes/2024-01-19/index.html#r-training-open-source",
    "title": "Minutes 2024-01-19",
    "section": "R Training Open Source",
    "text": "R Training Open Source\nAndy - Training material shared with Mike Smith and R consortium\nGet done by February - take a look and reassess once released"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#poster-ideas-clinical-flow-chart-diagram-for-r",
    "href": "minutes/2024-01-19/index.html#poster-ideas-clinical-flow-chart-diagram-for-r",
    "title": "Minutes 2024-01-19",
    "section": "Poster Ideas / Clinical Flow Chart Diagram for R",
    "text": "Poster Ideas / Clinical Flow Chart Diagram for R\nWhat makes good online training? Programming element\nLeveraging shiny apps for remote training - blog about it?\nCAMIS - Wilcoxon signed rank test\nGap - Look at from a statistician point of view\n\nSample size\nSubgroup analysis\n\nPharma statistics packages\nSimplifying pharmaverse - cannot simplify?"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#data-science-collaboration",
    "href": "minutes/2024-01-19/index.html#data-science-collaboration",
    "title": "Minutes 2024-01-19",
    "section": "Data Science Collaboration",
    "text": "Data Science Collaboration\nReaching out to data science SIG as a first step\nPotentially too much effort to push an idea forward\nSee where they are, what there focus is currently"
  },
  {
    "objectID": "minutes/2024-01-19/index.html#r-industry-working-groups-feedback",
    "href": "minutes/2024-01-19/index.html#r-industry-working-groups-feedback",
    "title": "Minutes 2024-01-19",
    "section": "R Industry Working Groups feedback",
    "text": "R Industry Working Groups feedback\nCAMIS (Lyn) - good recent progress - new people, new content, enthusiasm exponentially growing\nBusy!\nExpanded leadership with Harshal and Chi\nCan we get someone to either join R validation Hub or someone from there to join AIMS?\nOr just ask them for updates? Important to keep relationship\nSet up quarterly updates? Lyn reached out to Juliane and Doug\nPharmaverse (Christina) Looking to make Admiral more stable and preparing for conferences.\nRTRS (Christina) bookdown more stabilised - making more organic\nOpenstatsware updates from Kevin and website\nSubmissions working group updates from website\nAny other active working groups - none that we know of."
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About",
    "section": "",
    "text": "With the continual growth of the use of open-source software within the industry, it is important for statisticians, statistical programmers and data scientists to be aware of the latest developments and help to drive them forward. Open source software can provide faster technological advancements and wider sharing of new methods, which can make clinical trial development more efficient, allowing more focus to be on ‚ÄúPatients First‚Äù and getting medications to market as quickly and safely as possible."
  },
  {
    "objectID": "about.html#background",
    "href": "about.html#background",
    "title": "About",
    "section": "",
    "text": "With the continual growth of the use of open-source software within the industry, it is important for statisticians, statistical programmers and data scientists to be aware of the latest developments and help to drive them forward. Open source software can provide faster technological advancements and wider sharing of new methods, which can make clinical trial development more efficient, allowing more focus to be on ‚ÄúPatients First‚Äù and getting medications to market as quickly and safely as possible."
  },
  {
    "objectID": "about.html#aim",
    "href": "about.html#aim",
    "title": "About",
    "section": "Aim",
    "text": "Aim\nTo support and contribute to researching the use of R within the industry."
  },
  {
    "objectID": "about.html#current-goals",
    "href": "about.html#current-goals",
    "title": "About",
    "section": "Current Goals",
    "text": "Current Goals\n\nSupporting and influencing the working groups and collaborations that are happening within the industry\nIdentifying the key topics and areas of interest which require promotion, future research and development\nSharing knowledge and information on the above in appropriate ways with the PSI community (many of whom are not aware of or comfortable with open-source)\nUnderstanding what our adoption of the PSI digital strategy looks like\nEnsuring the industry stays up to date with technological advancement\nLooking to bring a statistical presence to discussions on R"
  },
  {
    "objectID": "about.html#members-and-affiliations",
    "href": "about.html#members-and-affiliations",
    "title": "About",
    "section": "Members and Affiliations",
    "text": "Members and Affiliations\n\n\n\n\n\nName\nCompany\nRole\n\n\n\n\nMartin Brown\nPPD Part of Thermo Fisher Scientific\nChair\n\n\nLyn Taylor\nParexel\n\n\n\nAndy Nicholls\nGSK\n\n\n\nChristina Fillmore\nGSK\n\n\n\nMatthew Neilson\nPhastar\n\n\n\nMin-Hua Jen\nEli-Lilly\n\n\n\nMichael Cartwright\nParexel\n\n\n\nMark Bynens\nJnJ\n\n\n\nYannick Vandendijck\nJnJ\n\n\n\nMarie-Laure Casadebaig\nIncyte\n\n\n\nIrene Vassallo\nIncyte\n\n\n\nSimone Modolo\nEvotec\n\n\n\nDavid White\nIQVIA\n\n\n\nSampath Madanu\nAZ"
  },
  {
    "objectID": "blogs/test/blog2openlandsbasics.html",
    "href": "blogs/test/blog2openlandsbasics.html",
    "title": "Open-Source Landscapes Basics",
    "section": "",
    "text": "R Introduction\nWhat is R? ‚Äì R: The R Project for Statistical Computing\n\n\n\n\n\n\n\n\n\nR is a powerful programming language and environment specifically designed for statistical computing and graphics. Born in the halls of academia in 1993, it has evolved into an essential tool in the statistical world, especially for clinical research.\nThink of R as your statistical workshop where:\n\nYou can perform sophisticated statistical analyses, from traditional hypothesis testing to cutting-edge adaptive designs\nCreate publication-quality graphics with precise control over every visual element\nHandle data of any size or structure with elegant efficiency\nAutomate repetitive tasks with custom functions\nShare and collaborate through reproducible code\n\n\n\n\n\n\n\n\n\n\nWhat makes R special is its modular framework and extensibility‚Äîit‚Äôs like having a basic toolkit that you can continuously enhance with specialized instruments. This is particularly valuable in clinical research, where methodological requirements can be highly specific and evolve quickly.\nDid You Know? üìù R was named after its creators‚Äô first initials (Ross Ihaka and Robert Gentleman) and as a playful reference to the S programming language it superseded.\n\n\nCRAN ‚Äì the Comprehensive R Archive Network ‚Äì CRAN\nYour one-stop package shop!\n\n\n\n\n\n\n\n\n\nCRAN is the treasure trove of over 22,000 packages that extend R‚Äôs capabilities in a multitude of ways ‚Äì statistical, graphical, AI, computational.\n\nWant to analyze time-to-event data? There are packages for that\nLooking to design adaptive clinical trials? Covered\nLooking to build machine learning models? Take your pick\n\n\n\nPackages and Dependencies\nR packages are like LEGO blocks‚Äîthey snap together to build something amazing. Here‚Äôs what you need to know:\n\nPackages are collections of R functions, data, and code\nDependencies are packages that need to be installed for your package to work\nInstallation can be as simple as: install.packages(‚Äúpackage_name‚Äù) and dependencies will install automatically\n\n\n\nOther Open-Source Languages\nWhile R excels in statistical computing and is the main open-source language currently being used in the industry, there are others:\n\nPython: Used extensively for machine learning, artificial intelligence, and deep learning applications. Popular for mathematics courses, processing real-world evidence data, natural language processing of medical texts, and developing prediction models for patient outcomes.\nJulia: A high-performance language specifically designed for numerical and scientific computing. Gaining traction in clinical trial simulations and complex mathematical modeling due to its exceptional speed, particularly useful for large-scale clinical trial simulations and pharmacometric analyses.\nJavaScript: Powers interactive applications and dashboards for clinical trial data visualization. Essential for creating dynamic, web-based reporting tools and interactive safety monitoring displays. Often used with R Shiny applications to enhance user interfaces.\nHTML: The foundation for web-based tasks. Essential for creating structured, accessible documentation that can be easily shared across organizations.\n\n\n\nIntegrated Development Environments (IDEs)\nAn Integrated Development Environment (IDE) is like a sophisticated text editor specifically designed for writing code. Instead of just typing R commands into a basic console, an IDE provides a complete workspace with helpful features like syntax highlighting (coloring your code for readability), error checking, code completion, and integrated help. Think of it as the difference between writing in a basic notepad versus using a modern word processor with spell check, formatting, and other helpful tools.\nThe right IDE can significantly improve your coding efficiency and help maintain good programming practices. It brings together all the tools you need - code editor, R console, file management, and visualization tools - into one organized interface.\n\n\nRStudio\nRStudio is the most widely used IDE for R programming in the pharmaceutical industry.\n\n\nRStudio Desktop\nThe free version of RStudio provides all essential features:\n\nCode editor with syntax highlighting\nR console for immediate output\nEnvironment pane showing your data and objects\nOutput panes for plots, files, packages, and help\nProject management capabilities\nBuilt-in Git integration\n\n\n\n\n\n\n\n\n\n\n\n\nPosit Workbench\nThe paid, enterprise version of RStudio is tailored for collaboration and scalability:\nKey Benefits:\n\nCentralized & Secure: Everyone works in the same validated environment through a web browser, rather than having R Studio installed on individual computers\nCollaboration: Multiple team members can work on the same projects and share code easily\nControl: IT departments can manage:\n\nWho has access to what\nWhich R versions and packages are available\nWhere data and code are stored\nHow resources (memory, CPU) are allocated\n\n\n\n\nAlternative IDEs\nOther IDEs are available and may be useful depending on your needs. Here are some examples:\n\nVisual Studio Code\n\nModern interface\nSupports multiple programming languages\nStrong debugging tools\n\nJupyter Notebook\n\nDocument-style analysis\nCombines code and documentation\nPopular for sharing analytical work\n\nPosit Positron\n\nNew desktop IDE from Posit\nModern, lightweight alternative to RStudio Desktop\nBuilt on VS Code technology\nSupports both R and Python\nCurrently in early adoption phase\n\n\n\n\nPopular Packages\nSo you have R in the R Studio IDE, let‚Äôs introduce some essential packages to start your journey.\n\n\nBase R: Your Foundation\nBase R comes pre-installed with your R installation and includes fundamental tools for:\n\nData structures (vectors, matrices, data frames)\nBasic statistical functions (mean, median, linear regression)\nSimple plotting capabilities\nFile input/output operations\n\nSee this helpful cheat sheet for basic commands ‚Äì r-cheat-sheet.key\nR comes with many built-in packages. Some are loaded automatically when you start R (like stats and graphics), while others are installed but need to be loaded with library() when you need them (like survival or MASS).\nWhile Base R is powerful, modern R programming often relies on additional packages that make coding more intuitive and efficient. This firstly leads us on to the tidyverse.\n\n\nTidyverse: Modern Data Science Tools ‚Äì Tidyverse\n\n\n\n\n\n\n\n\n\nThe tidyverse is a collection of packages designed to work together harmoniously for standard dataset tasks. Core packages include:\n\ndplyr: Data manipulation (filter, sort, summarize)\nggplot2: Creating professional graphics\ntidyr: Data cleaning and reshaping\nhaven: SAS data import\ntibble: Modern data frames\n\nExample of tidyverse syntax:\n# Base R approach\nsubset(data, Age &gt; 18)[, c(\"PatientID\", \"Treatment\")]\n\n# Tidyverse approach\ndata %&gt;% \n  filter(Age &gt; 18) %&gt;% \n  select(PatientID, Treatment)\n\n\nPharmaverse: Industry-Specific Tools ‚Äì Pharmaverse\n\n\n\n\n\n\n\n\n\nThe pharmaverse is a collection of packages specifically designed for clinical trial workflows. Here are some examples:\n\nadmiral: ADaM dataset creation following CDISC standards\nggsurvfit: Publication-ready survival plots and time-to-event analyses\nriskmetric: Risk assessment and validation of R packages\nlogrx: Standardized logging for clinical trial analysis\n\nThese packages work together to support regulatory-compliant clinical trial analysis workflows while maintaining reproducibility and traceability.\nGetting Started Tip: Most pharmaverse packages build on tidyverse principles, so becoming comfortable with tidyverse first will make learning industry-specific packages easier.\n\n\nQuick Start: Your First 5 Minutes with R\nLet‚Äôs walk through a complete example from installation to visualization. We‚Äôll analyse some survival data using just the essentials:\n# 1. Install and load just what we need\ninstall.packages(c(\"dplyr\", \"ggplot2\", \"survival\"))  # Only needed once\nlibrary(dplyr)              \nlibrary(ggplot2)            \nlibrary(survival)           \n\n# 2. Get some example data (built into survival package)\n?lung                       # Information on survival data from a cancer study\nhead(lung)                  # Quick look at first few rows\n\n# 3. Simple analysis: Calculate median survival time by sex\nlung_analysis &lt;- lung %&gt;%\n  mutate(sex = factor(sex, labels = c(\"Male\", \"Female\"))) %&gt;%\n  group_by(sex) %&gt;%\n  summarise(\n    n = n(),\n    median_time = median(time, na.rm = TRUE)\n  )\n\n# 4. Create a simple survival plot\nggplot(lung, aes(x = time, y = status, color = factor(sex))) +\n  geom_point(alpha = 0.5) +\n  labs( title = \"Survival Status by Time\", x = \"Time (days)\", y = \"Status\" )\n\n\nQuick Start Tips:\n\n‚úÖ Start RStudio\n‚úÖ Copy this code into a new script\n‚úÖ Run each section using Ctrl+Enter (Cmd+Enter on Mac)\n‚úÖ Save your script (File &gt; Save As‚Ä¶)\n\n\n\nCommon First-Time Issues:\n\n‚ùå Make sure to run library() after installation\n‚ùå Watch for typos - R is case-sensitive\n\nThat‚Äôs it! You‚Äôve just completed your first R analysis. From here, you can explore more packages as needed.\n\n\nFurther Reading and Links\n\nFurther Reading: ‚ÄúR for Data Science‚Äù by Hadley Wickham & Garrett Grolemund\n\nEssential guide for modern R programming\nFree online: R for Data Science eBook\n\nLinks:\n\nR: The R Project for Statistical Computing\nCRAN\nRStudio Desktop Download\nTidyverse\nPharmaverse"
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-psi-aims-sig",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-psi-aims-sig",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to PSI AIMS SIG",
    "text": "Introduction to PSI AIMS SIG\nOne of PSI AIMS SIGs objectives is to support and contribute to working groups researching and developing tools that will help us use R in Pharmaceutical research. These wide ranging working groups focus on replication across software, development of packages and tools, application of statistical methods in R and R submissions. This article introduces you to some of the most popular working groups, whose collective remit is to encourage and support the use of R in regulatory research. PSI AIMS SIG actively supports these projects so check out what each does below and become active by joining PSI AIMS SIG or one or more of the projects !"
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-phuse-camis",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-phuse-camis",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to PHUSE CAMIS",
    "text": "Introduction to PHUSE CAMIS\nCAMIS (Comparing Analysis Method Implementations in Software) is a PHUSE DVOST working group (WG) who have built an open-source repository containing guidance on the application of statistical methodology and replication of analysis methods across various software (including SAS, R and Python).\nPrevious industry reliance on SAS¬Æ software, resulted in a dependence on SAS¬Æ software default methods, and a lack of understanding about exactly how SAS implements various analysis methods.¬†¬† Statistical analysis plans (SAPs) are often written without full specification of the method.¬† This may not be an issue, if all analysts use SAS, however when CROs, Sponsors and Regulators are trying replicate each others' analysis, it's vital to fully specify how each method will be implemented, such that it can be replicated using any software and removing any ambiguity in the intended analysis method to be used.\nThis project was initially set up by PHUSE as the 'CSRMLW' WG, but leadership was taken over by PSI AIMS SIG members, who initiated a name change to: 'Comparing Analysis Method Implementations in Software'.¬† CAMIS WG found that when the same methods are used, then replication is often easy, but finding out exactly what method is being used by each software can be very time consuming.¬† A simple example would be using a Kaplan-Meier method to estimate the median time to death with 95% confidence interval (CI), the analyst needs to specify how to calculate the CIs.¬† The SAS default (log method) is not the same as the R default (log-log method) and often the method to use is not specified in the SAP!¬† Another example, is cox-proportional hazards modelling. The analyst should always state whether to use the SAS default method for tied observation times (Breslow) or the R default method (Efron) or another method!¬† Even logistic regression modelling, which is commonly used to obtain odds ratios and CIs, requires the analyst to specify if we are using SAS default (Wald CIs) or R default (Profile likelihood CIs). A lack of clear specification of methods, can result in an inability to reproduce the same results in different software. Especially as not all options are available in all software (e.g.¬†SAS cannot calculate profile likelihood CIs using proc logistic!).\nOther examples of replication issues include a lack of clarity in SAS¬Æ documentation for example; proc rmstreg, it states a default tau=maximum event time will be used, but it actually implements the maximum of the event or censoring time. CAMIS helps users to ensure correct model specification to avoid common pitfalls when software documentation is incorrect or unclear.\nCAMIS also improves confidence in packages, through bug fixing. CAMIS identified a bug in R {RBesT} package for a specific use-case of 0% or 100% responders, resulting in a lack of replication of this package vs other packages and SAS. CAMIS worked with the authors, and the package was fixed and re‚Äëreleased on CRAN as v1.8-0.¬† When doing Confidence intervals for proportions, there was no single package that did all the common methods needed.¬† For some methods, {DescTools} ‚Äì a miscellaneous basic stats package unlikely to be acceptable for GxP environment was the only option. CAMIS highlighted this issue to the industry, and work has begun to create a new package {citools} to meet this missing R functionality and industry need.\nCAMIS applies a variety of use-case studies, in an attempt to replicate results across software.¬† This provides the reader with 10 advantages!\n1)¬†¬†¬†¬† an easy-to-read guide for common medical research analysis in R, SAS and python,\n2)¬†¬†¬†¬† a comparison of results across the software,\n3)¬†¬†¬†¬† rationale for why differences exist (default options vs available options),\n4)¬†¬†¬†¬† common mistakes when interpreting the documentation which aids the user to correctly implement methods in programming code,\n5)¬†¬†¬†¬† details regarding background methodology (including use of continuity corrections or convergence methods) which can be highly technical statistically and often not well documented,\n6)¬†¬†¬†¬† identified bugs that exist in the software, gives advice re: workarounds or avoidance or works with authors to fix bugs improving quality of software\n7)¬†¬†¬†¬† identifies missing requirements in R, and collaborates to author new packages to fill these GxP needs.\n8)¬†¬†¬†¬† provides reassurance and confidence in the software (and packages) being used through cross software replication\n9)¬†¬†¬†¬† Highlights alternative open-source trusted macros, (for example, if procedures are not available in SAS, there may be SAS macros published that can be used).\n10)¬† provides time saving trustworthy guidance to avoid duplication of effort within the medical research industry\nTopics within the repository covered to date include, basic statistics, general linear models, generalized linear models, multiple imputation, survival modelling, non-parametric analysis, categorical data analysis, repeated measures, sample size and machine learning.\nCAMIS is an open source collaboration, and with your help, the repository will continue to grow in content and be a vital source for medical statisticians and programmers. ¬†See CAMIS - A PHUSE DVOST Working Group for the repository or how to Get Involved."
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-pharmaverse",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-pharmaverse",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to pharmaverse",
    "text": "Introduction to pharmaverse\npharmaverse is a connected network of companies and individuals working to promote collaborative development of curated open source R packages for clinical reporting usage in pharma, in a space where previously we would only ever have worked in silos on our own closed source and often duplicative solutions\nHistorically, when the majority of pharmaceutical companies and CROs were using SAS, each company developed it own set of SAS macros and tools aimed to improve for their company, the efficiency of clinical trial reporting in the regulatory environment.¬† This came with a number of challenges:\n1)¬†¬†¬†¬† New employees were not familiar with the inhouse systems or macros resulting in time consuming onboarding training\n2)¬†¬†¬†¬† Substantial investment had to be made by each company in order to develop and maintain internal processes and systems\n3)¬†¬†¬†¬† Processes and tools were slow to change or to modernize to new technology\nWith the ever increasing costs of clinical trials, companies needed to find cost saving methods, to adapt to survive, and hence started to get innovative with how new technology or software could help with this.¬† R's open-source ecosystem and modular, build and extend model framework, led to a positive shift in the mindset of developers. The realization that collaboration across companies not only leads a reduction in duplicated effort but also to a cycle of continuous feedback, improvement, advancement and increased efficiencies for all.¬† The companies who were early adopters of R, started to release their in-house developed packages, into the open source environment, and to invite community contributions and open source continual development.¬† And Thus!!¬† The Pharmaverse was born.\nThe collection of End-to-End Clinical Reporting Packages, provides tools for SDTM, ADaM, TLGs, e‚Äësubmissions, metadata handling, utility packages, and other useful tools, key to reporting of clinical trials and submissions.¬† Continual development of existing and new packages takes place in github repositories, where the community can raise issues (suggestions for enhancements or bugs) and collaborate on new version releases. ¬†The benefit to the pharma community is multi-faceted\n1)¬†¬†¬†¬† If companies use open source tools then less onboarding of new employees is required\n2)¬†¬†¬†¬† Collaboration allows for a larger pool of available talent to achieve more together, continually challenging the status quo and making improvements\n3)¬†¬†¬†¬† Community development helps to standardize processes improving efficiencies\nIn addition to packages that support production of TLGs, pharmaverse also contains a TLG Catalog - Stable.¬† This extensive catalog of common TFLs (including example for: AEs, conmeds, deaths, demography, ECGs, Efficacy, Labs, Medical History, PK and vital signs), is extensive.¬† It is yet to be seen if further cross company TLGs standardization is achievable, as if it were, it would radically reduce replication of efforts.¬† Seepharmaverse for more information."
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-openstatsware",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-openstatsware",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to openstatsware",
    "text": "Introduction to openstatsware\nopenstatsware is a scientific working group of the American Statistical Association (ASA) Biopharmaceutical section (BIOP) and a European Special Interest Group (SIG) sponsored by Statisticians in the Pharmaceutical Industry (PSI) and the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI).\nTheir goals are to:\n1) Engineer selected R-packages to fill in gaps in the open-source statistical software landscape\n2) Develop good software engineering practices\n3) Communicate, collaborate and promote their work in the community\nThe skillset of a statistician was traditionally very different to that of a software engineer. Statisticians developing statistically technical R packages often released good quality packages, but ones that lacked a clear software development lifecycle and associated good practices such as adequate code coverage testing. ¬†With the rapid interest in using R for regulated medical research, it became apparent that some of the common analysis performed standardly for clinical trials in SAS, was not easily available in R.\nGiven that the average statistician would be very daunted by the prospect of developing a new R package, there was concern that this may be holding back the development of much needed statistical methods packages. Openstatsware writes articles and delivers presentations on good software engineering practices, in addition to identifying gaps in our software tools and setting up workstreams focusing on developing solutions to fill these gaps.¬† They currently have four workstreams:\n\nMMRM: Mixed models for repeated measures are a popular choice for analyzing longitudinal continuous outcomes. However, the models come with a wide range of methods and techniques such as a choice of covariance matrices, weightings of observations, fitting models with restricted or standard maximum likelihood inference and performing hypotheses testing with Satterthwaite or Kenward-Roger adjustment. There was an unmet need in R, making it hard to fit MMRMs and reproduce analysis performed in SAS. The {mmrm} package release filled this gap, and has become the go-to package for all R users fitting MMRMs in the pharmaceutical industry and beyond.\nBayesian MMRM: following the release of R package {mmrm}, it was clear that although {brms} was powerful, an additional package was needed to leverage that to run MMRMs. ¬†The release of the R package {brms.mmrm} filled that gap, enabling users to fit Bayesian repeated measurement models.\nHTA-R workstream: this workstream's objective is to develop open-source R tools of good quality in the right formats (R packages, apps, user guides) that are useful to both manufacturers and payers, to support crucial analytic topics in HTA dossier submission across various countries, particularly the topics with unmet needs in R implementation and/or related to EUnetHTA.\nBayesian Safety Signal Detection Julia Package: this workstream's objective is to develop a Julia package for Bayesian Safety Signal Detection based on the Brock et¬† al (2021) method.\n\nSee openstatsware for more information."
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-r-validation-hub",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-r-validation-hub",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to r validation hub",
    "text": "Introduction to r validation hub\nR Validation Hub is a cross-industry initiative whose mission is to enable the use of R by the Bio-Pharmaceutical Industry in a regulatory setting, where the output may be used in submissions to regulatory agencies.\nOne of the earliest working groups initially set up by the PSI AIMS SIG in 2018 to investigate what was preventing the pharmaceutical industry using R, the R Validation Hub has gone on to provide the community with a number of ground-breaking deliverables.\n\nWhite paper. In 2020, they released a white paper which introduced the concept of a risk-based approach to assessing R packages. ¬†The framework quickly attracted wide industry agreement, that there is minimal risk in using Core R (base + recommended) packages for regulatory research. The hub showed how Core R, plus a pipeline for risk based assessment of contributed packages and controlled access of packages, can collectively be used as a GxP approved R environment. ¬†A Risk-based Approach for Assessing R package Accuracy within a Validated Infrastructure Nicholls, Bargo, Sims (2020).\n{riskmetrics} package and {riskassessment} app. A further problem was how we can assess package risk and collect metrics on packages.¬† {riskmetrics} provided one solution to this problem, scraping data from a variety of sources and providing a summary of 'trustworthyness' based on both maintenance metrics and community usage metrics. The accompanying {riskassessment} app reported these metrics in a visually appealing way, also allowing a report to be output which could be saved for documentation of decisions made about packages.\nDuring 2022-2023 a series of R adoption talks and case studies provided a transparency rarely seen previously in pharmaceutical research.¬† These talks made public many companies plans and methods to start to do statistical analysis reporting in R and/or transition to R fully.\n\nThe R validation hub is still identifying and addressing issues and challenges with R implementation, and offers a range of free webinars throughout the year encouraging discussion and collaboration on a range of topics.¬† See R Validation Hub for more information."
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-r-consortium-r-submission-pilot",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-r-consortium-r-submission-pilot",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to R Consortium R Submission Pilot",
    "text": "Introduction to R Consortium R Submission Pilot\nR Submission Pilot: focusing on IT and platform challenges, their goal is to identify and address issues in order to make 'all R' regulatory submissions\nThis working group have worked through a number of pilot submissions, in order to identify and address issues associated with doing regulatory submissions to the FDA using R alone.¬† Their initial pilot submission in Nov 2021, focused on the delivery of Tables and Figures which had been produced using R. Their second pilot delivered the same tables and figures, but the submission included a Shiny App for the output creation within the submission package. The third pilot demonstrated production of both ADaM and TFLs using R. Pilot 4 is still in progress, exploring use of novel technologies such as Linux containers and web assembly to bundle a Shiny application into a self-contained package, facilitating a smoother process of both transferring and executing the application.¬† Pilot 5 is planned for November 2025 and will explore delivery of datasets in datasetjson files instead of xpt. See Introduction ‚Äì R Submissions Working Group for more information."
  },
  {
    "objectID": "blogs/test/open-source-stats-resources.html#introduction-to-r-consortium-r-tables-for-regulatory-submissions-rtrs",
    "href": "blogs/test/open-source-stats-resources.html#introduction-to-r-consortium-r-tables-for-regulatory-submissions-rtrs",
    "title": "PSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups",
    "section": "Introduction to R Consortium R Tables for Regulatory Submissions (RTRS)",
    "text": "Introduction to R Consortium R Tables for Regulatory Submissions (RTRS)\nGoal is to create standards for creating tables that meet the requirements of FDA submission documents, and hence enhance the suitability of R for FDA submissions\nThis working group was set up to demonstrate best practices and standards for the creation of TLGs in R, that would meet the requirements of submissions.¬† Their detailed bookdown Tables in Clinical Trials with R describes packages that aid production of TLGs also addresses requirements such as titles, footnotes, captions, pagination and rendering.¬† Commonly used tables are demonstrated showing the code and outputs. The activity of this group has been quite since mid 2024, likely due to the rapid advancement of pharmaverse TLGs ¬†and the associated TLG Catalog - Stable."
  },
  {
    "objectID": "blog.html",
    "href": "blog.html",
    "title": "Blog",
    "section": "",
    "text": "Date\n\n\n\nTitle\n\n\n\nAuthor\n\n\n\n\n\n\n\n\n¬†\n\n\nPSI AIMS SIGs Guide to Open-Source Stats Resources and Working Groups\n\n\n¬†\n\n\n\n\n\n\nOct 16, 2025\n\n\nHow to Choose an R Package for Statistics\n\n\nPSI AIMS\n\n\n\n\n\n\nSep 15, 2025\n\n\nOpen-Source Landscapes Basics\n\n\nPSI AIMS\n\n\n\n\n\n\nMay 13, 2025\n\n\nWhy Open-Source Skills are Important\n\n\nPSI AIMS\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "posts/test/FDApilot3.html",
    "href": "posts/test/FDApilot3.html",
    "title": "FDA Pilot 3 submission",
    "section": "",
    "text": "The R Consortium is pleased to announce that on August 28, 2023, the R Submissions Working Group successfully submitted an R-based test submission pilot 3 package through the FDA eCTD gateway! The FDA CDER staff are now able to begin their evaluation process. All submission materials can be found at: https://github.com/RConsortium/submissions-pilot3-adam-to-fda¬†\nThe pilot 3 test submission is an example of an all R submission package following eCTD specifications. These include the installation and loading of the proprietary {pilot3} R package and other open-source R packages, R scripts for the analysis data model (ADaM) datasets from pilot 3 and tables, listings, figures (TLFs) from pilot 1, analysis data reviewer‚Äôs guide (adrg), and other required eCTD components. To our knowledge, this is the first publicly available R-based FDA submission package, which includes R scripts to generate ADaM datasets and TLFs. We hope this submission package and our learnings can serve as a good reference for future R-based regulatory submissions from different sponsors. Additional agency feedback will be shared in future communications.¬† For any future questions, you may contact the pilot 3 team here: https://rconsortium.github.io/submissions-pilot3-adam/main/index.html.\nSee here for more information about pilot 1, 2, 3 and the future plans for pilot 4."
  },
  {
    "objectID": "posts/test/CAMIS2023.html",
    "href": "posts/test/CAMIS2023.html",
    "title": "2023: A Year of Progress for PHUSE CAMIS Working Group",
    "section": "",
    "text": "As we draw towards the end of 2023, the PHUSE CAMIS Working Group reflect on their key progress and successes this year. The CAMIS repository went live in January 2023, drawing on the content from the PHUSE CSRMLW project. This searchable repo compares analysis method implementations in software (CAMIS) such as SAS, R and python.\nThe White Paper was published in June, which highlighted the importance of clearly specifying your analysis, such that it can be replicated in different software, and isn‚Äôt relying on default options which can be different. For more complex analyses, it can still be hard to understand what defaults and algorithms your software is using, so the team focused 2023 on expanding our repo content, comparing SAS vs R methods. By August, we had covered the following topics in the repo: quartiles, rounding, anova, mmrm, cmh, log-rank, cox-ph, mcnemar‚Äôs test, kruskal-wallis test and logistic. October saw the launch of the sub-working group: CAMIS-Oncology, led by Somasekhar Sriadibhatla (AstraZeneca). This team will focus specifically on oncology endpoints and analyzing them in SAS, R and Python. The CAMIS team have expanded in membership during 2023 presenting at numerous conferences around the world. In November, we welcomed Harshal Khanolkar (NovoNordisk), to join the leadership team alongside Christina Fillmore (GSK) and Lyn Taylor (PAREXEL). Our focus for 2024, will be on the creation of additional content for the repo, and sharing awareness of the project across the medical research and wider community. We‚Äôd like to take this opportunity to thank all of our team members and contributors, and encourage everyone to check out the repository and help us to grow our content CAMIS (psiaims.github.io). If you would like to join the team please get in touch through the repo."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "PSI AIMS Special Interest Group",
    "section": "",
    "text": "The Application and Implementation of Medical Statistics (AIMS) Special Interest Group (SIG) objective is to support and contribute to working groups researching the use of R in Pharma such as the R consortium working groups, R validation Hub, other SIGs (Data science/Visualization), PhUSE, Pharmaverse and Transcelerate and share this information with the wider PSI community.\n\n\n\n\nCollaboration\n\n\nNews\n\n\n\n\nWhy R?\n\n\n\n\n\nResources\n\n\n\n\nStatistics\n\n\nPSI and Pharma"
  },
  {
    "objectID": "minutes.html",
    "href": "minutes.html",
    "title": "Meeting Minutes",
    "section": "",
    "text": "Order By\n      Default\n      \n        Date - Oldest\n      \n      \n        Date - Newest\n      \n      \n        Title\n      \n    \n  \n    \n      \n      \n    \n\n\n\n\n\n\nDate\n\n\n\nTitle\n\n\n\n\n\n\n\n\nMar 15, 2024\n\n\nMinutes 2024-03-15\n\n\n\n\n\n\nFeb 16, 2024\n\n\nMinutes 2024-02-16\n\n\n\n\n\n\nJan 19, 2024\n\n\nMinutes 2024-01-19\n\n\n\n\n\n\nNo matching items"
  },
  {
    "objectID": "posts/test/index.html",
    "href": "posts/test/index.html",
    "title": "R and FDA Submission",
    "section": "",
    "text": "Check out the following exciting webinar on R and FDA submissions:"
  },
  {
    "objectID": "posts/test/ChgManSDEJul25.html",
    "href": "posts/test/ChgManSDEJul25.html",
    "title": "One Day meeting on Change Management in the Transition to Open-Source / R",
    "section": "",
    "text": "This was a very successful event where 70+ people attended to discuss change management issues in Open-Source including training, organisational change and managing during times of big changes, communicating to colleagues and managers, timing and resourcing change. The audience were split across Pharma (46%), CRO (41%), Biotech (4%) and other affiliations including academia. The audience were pretty evenly split between those that used R and open-source tools regularly (49%) and those that used it infrequently or not at all (51%). Our 9 speakers presented on many topics, covering managing change at larger pharma companies where they have already made the move to open-source tools, but also presenting the view from CROs where use of open-source tools is growing but not yet established. Training, support and preparedness for change was a common theme in presentations ‚Äì being ready for the journey and whatever happens along the way.\nThe audience were very engaged and asked interesting questions many of which we covered as part of a panel discussion. Common themes in questions included resourcing for change when the day job doesn‚Äôt allow much additional time and resource to do so; how AI might help with changing from one software and programming language to another; addressing management and IT organisation questions about moving to new systems and the return on investment. At the end of the day, delegates were invited to reflect and think about next steps in group discussion ‚Äì what is the next action to take within their organisation, what are the ‚Äúquick wins‚Äù or proofs of concept that might convince others within their organistion, and how to ‚Äúunlock‚Äù acceptance of open-source.\nFeedback from delegates was very positive and we will aim to provide some resources for delegates and those that did not attend ‚Äì the first of which, the presentations from the day, can be found below. PSI AIMS and PhUSE Open Source Technologies for Clinical Data Analysis (OSTCDA) working groups will benefit from this event enormously, having a better understanding of industry needs and looking to provide more support and material in this area. As there also seemed to be support for a follow-on meeting, the obvious next steps for the groups would be to organise more events which could be online or in person.\n\nMike Smith - Pfizer - Change Management\nAndy Nicholls - GSK - From Training to Practice: A shift to Just in Time User Support\nMartin Brown - PPD - Change Management in a Large CRO; Investing for the Future\nKieran Martin - Roche - Getting Ready for submission with R\nStuart Malcolm - Veramed - Planning on R? \u000bRisk, Resources and Realism\nYannick Vandendijck - Johnson & Johnson - SAIL.R ‚Äì Journey Towards R Software for Statisticians in Johnson & Johnson\nRuhul Amin - AZ - R in Biometrics - AstraZeneca approach to enable R Shiny apps for Drug Project activities\nSebastia Barcelo - Cytel - Navigating Change in a CRO ‚Äì What I Wish I Knew 5 Years Ago About Transitioning to R\nColin Gillespie - Jumping Rivers - Can I trust this package?"
  },
  {
    "objectID": "rcollaborations.html",
    "href": "rcollaborations.html",
    "title": "R Collaborations",
    "section": "",
    "text": "This is an embedded &lt;a target=\"_blank\" href=\"https://office.com\"&gt;Microsoft Office&lt;/a&gt; presentation, powered by &lt;a target=\"_blank\" href=\"https://office.com/webapps\"&gt;Office&lt;/a&gt;."
  },
  {
    "objectID": "blogs/test/openskillintro.html",
    "href": "blogs/test/openskillintro.html",
    "title": "Why Open-Source Skills are Important",
    "section": "",
    "text": "Introduction\nIn a pharmaceutical industry that is rapidly changing and evolving, there can be many reactions to open-source, from worry and fear on the one side, to over-excitement and ‚Äòjumping on the band-wagon‚Äô on the other. The aim of this blog post and others throughout the year from the PSI AIMS SIG is to show that open-source skills are important. They can increase your work efficiencies and enhance your career, whatever type of statistician or data scientist you are! Therefore, we will be presenting a range of essential skills and foundational concepts in a clear and accessible manner through these blog posts.\n\n\nWhat do open-source skills bring?\nOpen-source is a positive shift in mindset challenging the status quo incorporating the following traits:\n\nFaster innovation\nIncreased efficiency\nModular, build-and-extend models\nBetter collaboration\nStandardised test frameworks\nContinuous arrival of new methods and tools being written\n\nBut this does not mean that every statistician needs to become a software engineer! A natural misconception with a new coding language, is that you need to become a deep expert of all its aspects, to use it effectively. In fact, the big positive of open-source is that many different types of people can use it effectively, in small and large ways, effectively leaning on each other - ‚ÄúStanding on the shoulders of giants‚Äù!. The following Venn diagram picks out 3 main ‚Äòstatistician‚Äô types:\n\n\n\n\n\n\n\n\n\n\n\nWhere do I begin?!\nWhatever type of statistician you are, you can benefit from understanding the basics of various skills, concepts and terms. As everything is moving forward quickly and there is an abundance of ‚Äògoogle‚Äô knowledge, it is hard to know where to start. We want to help you, through provision of these blogs!\n\n\nIntroducing Open Source Skills\nOver this series of blog posts, we will look at and introduce you to some key areas:\n\nOpen source landscape basics (R version, IDEs, package versions, terms, different setups, lots can change)\nHow do I find / review packages?\nPopular open-source stats resources (CAMIS, Pharmaverse, AIMS, Openstatsware etc.)\nGood coding practices (style guides)\nCollaborating with people on packages (CRAN email, GitHub intro)\nHow to file a GitHub issue\nHow to carry out a GitHub pull request\nContainers introduction\nParallelization ‚Äì what is the minimum amount I need to understand about the system to be successful?\n\n\n\nConclusion\nOpen-source skills are a crucial asset in the pharmaceutical industry, offering a wealth of opportunities to enhance your work day and career. Regardless of your role‚Äîwhether you‚Äôre a project statistician, statistical data scientist, or methodologist‚Äîembracing open-source software can lead to faster innovation, better collaboration, and a continuous influx of new methods and tools. Stay tuned for our upcoming blog posts, where we‚Äôll dive deeper into the open-source landscape basics, share practical tips for finding and using packages, and guide you through essential coding practices. You‚Äôll learn how to collaborate effectively, contribute to the community, and leverage these tools to drive your projects forward. Get ready to unlock the full potential of open-source skills and transform the way you work!"
  },
  {
    "objectID": "blogs/test/package-review.html",
    "href": "blogs/test/package-review.html",
    "title": "How to Choose an R Package for Statistics",
    "section": "",
    "text": "When you want to implement statistical methodology in R and you don‚Äôt already know the package that does the method, it can be difficult to figure out the ‚Äúbest‚Äù package. Sometimes when you google a method, the top result is the package with wording that matches closest to what you typed into google, rather than the package that is ‚Äúbest‚Äù for the method. You don‚Äôt want to waste time looking deeply into a package only to find there is a more common and robust R package out there for the same method. So before you go down a rabbit hole on one package, it is worth checking a few packages. But, how do you ‚Äúcheck‚Äù a package. This blog post will go through a worked example of comparing packages and a checklist of things to look at when comparing packages in the future."
  },
  {
    "objectID": "blogs/test/package-review.html#package-checklist",
    "href": "blogs/test/package-review.html#package-checklist",
    "title": "How to Choose an R Package for Statistics",
    "section": "Package Checklist",
    "text": "Package Checklist\nWhen looking at a package the first place to start is the CRAN index page. You can find this by googling CRAN and name of the package. From there you want to ask yourself the following questions:\n\nIs this package being actively maintained?\nIs the author known in the field?\n\nIs there more than one author?\n\nDoes the package have adequate documentation?\n\nAre there references to external peer reviewed papers?\nIs there a website or vignettes?\n\nIs there a way to report bugs?\nCan the packages handle different edge cases?\nDoes the package have a lot of dependencies / unusual dependencies?\nHow much has the statistical community or industry adopted it?\n\nUsing this checklist can help you quickly and consistently get a sense of a package before spending time looking into the code directly. Let‚Äôs see how this works in practice."
  },
  {
    "objectID": "blogs/test/package-review.html#worked-example-wilcoxon-rank-sum-test",
    "href": "blogs/test/package-review.html#worked-example-wilcoxon-rank-sum-test",
    "title": "How to Choose an R Package for Statistics",
    "section": "Worked Example: Wilcoxon Rank-Sum Test",
    "text": "Worked Example: Wilcoxon Rank-Sum Test\nTo think this through, we are going to look at a specific worked example - the Wilcoxon Rank-Sum test and the associated Hodges-Lehmann confidence interval. After googling for a little while, I found three different packages that do a Wilcoxon Rank-Sum p-value and Hodges-Lehmann CI:\n\nstats (part of base R)\npairwiseCI\ncoin\n\nGreat! I might be kind of done, because I tend to favor base R stats functions, but as I start looking into this, I found the stats function can‚Äôt handle ties if I want the exact methods. So I need to look into and compare the pairwiseCI and coin packages.\n\n\n\n\n\n\nTip\n\n\n\nYou often find that differences between packages and software show up when there are ties, missing data, and/or extreme values, so it is good to try to include these in the dataset you are using to compare.\n\n\nNow I need to choose between pairwaiseCI and coin. I could just run the model in both and see if the results match, but that will be a lot of work. So before I get started I want to go through our checklist.\nLet‚Äôs pull up the CRAN index pages for each of these packages and see if we can figure out which package we should use for this analysis.\n\npairwiseCI\nStarting with pairwiseCI, the index page looks like this:\n\n\n\n\n\n\n\n\n\nNow let‚Äôs go down the checklist to see if there are any red flags for this package.\n\nIs this package being actively maintained?\n\nThe last update to this package was 2019-03-11, so over 6 years at the writing of this post. That indicates this probably isn‚Äôt being actively maintained.\n\nIs the author known in the field?\n\nPersonally, I don‚Äôt know this author, but it looks like he does work in a biostatistics department at a university, so that is a really good sign. When you are looking at the author you don‚Äôt need to go super in-depth, but if you don‚Äôt know who they are it can be good to check their qualifications.\n\n\nIs there more than one author?\n\nYes, it looks like there are two authors here. This can be good to check because it can mean the burden of maintaining the package is shared and the documentation has potentially been peer reviewed.\n\n\nDoes the package have adequate documentation?\n\nThis can be hard to determine from just this index page, but the sub-questions can help here.\n\n\nAre there references to external peer reviewed papers?\n\nOn the index there are no references, but there might be some references on the function level. Really it just means they haven‚Äôt published a paper about this package.\n\nIs there a website or vignettes?\n\nThere isn‚Äôt a website or vingettes. This means all the documenation will be limited to just the functions, which can be harder to understand.\n\n\nIs there a way to report bugs?\n\nThere doesn‚Äôt appear to be a standard way to report bugs. If this package was on github or something similar, I would be able to check any issues there to see if others had similar problems or if the issue was caused by user error and has a quick fix.\n\nCan the packages handle different edge cases?\n\nThe description doesn‚Äôt say anything about handling special cases. But, I did find this package because it can handle ties in the exact case.\n\nDoes the package have a lot of dependencies / unusual dependencies?\n\nIt looks like this package only has two dependencies, MCPAN and, interestingly, coin, the other package we are looking at.\n\n\nOkay, having gone through all but the final question, I would say I do not feel great about the package, but if it was my only option I would still try to use it. The author gives me confidence in the package, but other things like documentation and last update date make me a bit nervous about this package.\n\n\ncoin\nNow on to coin with the same questions. The index page is as follows:\n\n\n\n\n\n\n\n\n\n\nIs this package being actively maintained?\n\nThe last update to this package was 2023-09-27, so more recently than {pairwiseCI}.\n\nIs the author known in the field?\n\nAgain, I don‚Äôt know the author, but he has an R-project.org email, which indicates he is very involved in the R ecosystem and is a very good sign.\n\n\nIs there more than one author?\n\nYes, there are 5 different authors, so lots of eyes on bugs and documentation.\n\n\nDoes the package have adequate documentation?\n\nAgain, this can be hard to determine from just this index page, but the sub-questions can help here.\n\n\nAre there references to external peer reviewed papers?\n\nYes, there is a peer reviewed paper in the description of this package.\n\nIs there a website or vignettes?\n\nWhile there isn‚Äôt a website here, there are four different vignettes.\n\n\nIs there a way to report bugs?\n\nLike with the other package, there doesn‚Äôt appear to be a standard way to report bugs.\n\nCan the packages handle different edge cases?\n\nSame as above. It doesn‚Äôt directly say it can handle our edge case, but I know it can.\n\nDoes the package have a lot of dependencies / unusual dependencies?\n\nWhile this package has more dependencies, all the dependencies are very standard and do not raise any red flags for me\n\n\nHaving gone through the questions, I am fairly confident in saying I want to use coin to investigate this method rather than pairwiseCI. For almost all of the questions coin looks slightly better than pairwiseCI and really just has a larger accumulation of evidence of quality. But, I haven‚Äôt answered the last question in my checklist for either of these packages - How much has the statistical community or industry adopted it? It can be a bit hard to look at directly, but I tend to investigate this a few different ways.\nFirst, staying on the CRAN index page for the package, I look at the Reverse Dependencies. This section gets split into three parts, ‚ÄúReverse depends‚Äù, ‚ÄúReverse imports‚Äù, and ‚ÄúReverse suggests‚Äù which explains how the other packages are using the package. In terms of community adoption, it doesn‚Äôt matter if other packages are depending on, importing or suggesting the package. All that matters is that they are using it. Note: This section only appears if other packages on CRAN use the package.\nFor these two packages, only coin has this section and we can see there are many other packages that use coin.\n\n\n\n\n\n\n\n\n\nThe next thing I will check is the number of downloads. This can easily be done with the following bit of code:\n\ncranlogs::cran_downloads(package = c(\"coin\", \"pairwiseCI\"))\n\n\n\n\n\n\n\n\n\n\nAnd you can see coin is much more popular than pairwiseCI.\nSo with all of this information, I think starting with coin is going to be the best use of my time.\nWhen looking at the number of downloads, you can look over a longer period like over the last month (by using the when parameter) or you can look between specific dates (by using the from and to parameters). But, it will give you the download numbers for each day, which you will need to summarise. These day-by-day numbers can be very helpful to look at trends, especially when there is a new package that is getting rapidly adopted.\nPlease note that this checklist isn‚Äôt intended to replace a full review of the package for GxP workflows. But it is intended to be helpful when starting to think through the issues involved in package choice particularly for statistical methods."
  },
  {
    "objectID": "blogs/test/package-review.html#summary",
    "href": "blogs/test/package-review.html#summary",
    "title": "How to Choose an R Package for Statistics",
    "section": "Summary",
    "text": "Summary\nIn summary, selecting the appropriate R package for statistical analyses is hard. Google isn‚Äôt perfect and so it is worth finding a few packages and going through this checklist. By taking a few minutes to consider factors like maintenance, documentation, and community adoption can save you time in the long run."
  },
  {
    "objectID": "test-page.html",
    "href": "test-page.html",
    "title": "test",
    "section": "",
    "text": "This is a test, yes\n\n\nCollaboration\n\n\nNews\n\n\n\n\nWhy R?\n\n\n\n\n\nResources\n\n\n\n\nStatistics\n\n\nPSI and Pharma"
  },
  {
    "objectID": "minutes/2024-03-15/index.html",
    "href": "minutes/2024-03-15/index.html",
    "title": "Minutes 2024-03-15",
    "section": "",
    "text": "TipView Attendee List\n\n\n\n\n\n\nMartin Brown\nMichael Cartwright\nMatthew Neilson\nCamilo Rojas Cifuentes"
  },
  {
    "objectID": "minutes/2024-03-15/index.html#publicising",
    "href": "minutes/2024-03-15/index.html#publicising",
    "title": "Minutes 2024-03-15",
    "section": "Publicising",
    "text": "Publicising\nGet into habit of posting news and putting it on linkedin - reshares etc. Get traffic going to the site. Not looking for lengthy blog posts but efficient news. Camilo to check out analytics on GitHub for website traffic. If you have any news - either put it on the site or flag it up to me. Plan to meet with Alexander Schact for his podcast to flag up the work of AIMS and pull multiple people to our website and resources."
  },
  {
    "objectID": "minutes/2024-03-15/index.html#phuse-us-connect",
    "href": "minutes/2024-03-15/index.html#phuse-us-connect",
    "title": "Minutes 2024-03-15",
    "section": "Phuse US Connect",
    "text": "Phuse US Connect\nNext time ask Mark and others about particular highlights from Phuse US Connect and other feedback."
  },
  {
    "objectID": "why-r.html",
    "href": "why-r.html",
    "title": "Why R?",
    "section": "",
    "text": "SAS has been a long standing pharmaceutical industry standard for GXP work, so it‚Äôs understandable that proposing to change to alternative software, would be met with resistance and trepidation. However, it‚Äôs important to ask yourself ‚ÄúWhy R?‚Äù, why is there a shift by companies to start to use R alongside SAS (or even replacing SAS)? Some key justification are provided below, which could be used to persuade reluctant adopters that there truly is a business case for R adoption (and for open source collaboration in general).\n\nWhy open-source software?\nOpen-source is a positive shift in mindset incorporating the following traits:\n\nAdapt to survive\nUse-and-improve\nChallenge the status quo\nContinuous feedback\nSelf-service learning\nCollaborate\n\n\n\nR ecosystem synergies result in resource efficiencies and cost savings\nR and python ecosystems are ideal for analytic engineering:\n\nModular, build-and-extend model\nFully integrated help documentation with further user-guide capabilities via quarto (markdown)\nStandardised test frameworks\nContinuous arrival of new methods and tools being written\nInteroperability between R python and the wider Data Science ecosystem (multi-language code usage)\nNo purchase costs\n\nCollaboration allows for a larger pool of available talent to achieve more together:\n\nReduces duplication of work being conducted within each company\nEasy re-use of code\nEngineering efficiencies (built in documentation/test frameworks/re-use of code & tools)\n\n\n\nEnhanced graphics & reporting capabilities\nThe following are just a few of the Enhanced graphics & reporting capabilities offered when using open-source software\n\nBrilliant graphics and interactive graphics\nInteractive story-telling capabilities through Shiny\nDynamic/automated reporting through quarto (rmarkdown)\nMetadata efficiencies\nSupports advanced analytics\n\n\n\nLarger community support\n\nR community user support is larger than any purchased software company could provide\nA wealth of information, help and advice available for free online\n\n\n\nIndustry trend\nSubstantial work ongoing to support the use of R within pharma. This is highlighted by the number of cross industry working groups addressing each of the areas of previous concern\n\npharmaverse\nR Submissions working group\nRTRS working group\nR Validation Hub\nCAMIS\n\n\n\nTalent attraction and retention\nThe pharmaceutical industry has always struggled to bring in enough experienced SAS programmers and statisticians. Open source languages and tools will lead to a bigger pool of available talent to work in the pharmaceutical industry. New starters (Uni leavers) will know R and data science tools already. Talent from other academic and industry fields may want to transition into pharma increasing our talent pool. Learning from each other enables the industry to move adapt quicker and embrace new technilogy quicker which leads to more efficiencies and cost savings\n\n\nIncreased opportunities for cross-pharma standardization/Reduced burden for individual companies\nCurrently each company writes their own specific processes, SAS macros and tools. This time is ‚ÄúNon-billable time‚Äù, at a cost to the company. pharmaverse are providing open source industry wide standard macros for SDTM, ADaM, TFLs and tools. Moving to open source languages and tools would have the following benefits:\n\nReduced cost, burden and duplication of effort for individual companies - increased efficiencies\nPackage/macro support and documentation thorough and complete\nTransferable knowledge when people move companies as staff are familiar with open source macros and do not have to re-learn individual company macros and tools\nStandardized SDTM, AdAM & TFLs means less project specific bespoke programming for common analyses / endpoints\nFrom limited static approach per company to multiple innovative collaborative approaches\nModular building of packages/macros enables quick adoption of new more efficient methods"
  },
  {
    "objectID": "rinpharma.html",
    "href": "rinpharma.html",
    "title": "R Collaborations",
    "section": "",
    "text": "Work in Progress!\n\nThis is an embedded &lt;a target=\"_blank\" href=\"https://office.com\"&gt;Microsoft Office&lt;/a&gt; presentation, powered by &lt;a target=\"_blank\" href=\"https://office.com/webapps\"&gt;Office&lt;/a&gt;."
  }
]